Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin Bresinsky

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|July 16, 2024
Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake SignalMelanie Walter, Merlin Bresinsky, Oliver Zimmer, et al.
Journal of Medicinal Chemistry|October 31, 2023
Development of Fluorescent AF64394 Analogues Enables Real-Time Binding Studies for the Orphan Class A GPCR GPR3Merlin Bresinsky, Aida Shahraki, Peter Kolb, et al.
Scientific Reports|August 9, 2020
NanoBRET binding assay for histamine H<sub>2</sub> receptor ligands using live recombinant HEK293T cellsLukas Grätz, Katharina Tropmann, Merlin Bresinsky, et al.
European Journal of Medicinal Chemistry|February 6, 2021
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H<sub>2</sub>R and D<sub>3</sub>RSabrina Biselli, Merlin Bresinsky, Katharina Tropmann, et al.
Journal of Medicinal Chemistry|June 10, 2021
Abolishing Dopamine D<sub>2long</sub>/D<sub>3</sub> Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H<sub>2</sub> Receptor AgonistsKatharina Tropmann, Merlin Bresinsky, Lisa Forster, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2021
Cardiac Effects of Novel Histamine H<sub>2</sub> Receptor AgonistsUlrich Gergs, Maren L Büxel, Merlin Bresinsky, et al.
Archiv Der Pharmazie|June 1, 2022
Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysisMerlin Bresinsky, Jessica M Strasser, Alexander Hubmann, et al.
ACS Chemical Neuroscience|May 6, 2022
Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 TauopathyGurpreet Singh, Peng Liu, Katherine R Yao, et al.
European Journal of Medicinal Chemistry|December 2, 2020
Structural modifications in the distal, regulatory region of histamine H<sub>3</sub> receptor antagonists leading to the identification of a potent anti-obesity agentKatarzyna Szczepańska, Steffen Pockes, Sabina Podlewska, et al.
ACS Pharmacology & Translational Science|January 21, 2022
Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314Merlin Bresinsky, Jessica M Strasser, Bernadette Vallaster, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|July 16, 2024
Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake SignalMelanie Walter, Merlin Bresinsky, Oliver Zimmer, et al.
Journal of Medicinal Chemistry|October 31, 2023
Development of Fluorescent AF64394 Analogues Enables Real-Time Binding Studies for the Orphan Class A GPCR GPR3Merlin Bresinsky, Aida Shahraki, Peter Kolb, et al.
Scientific Reports|August 9, 2020
NanoBRET binding assay for histamine H<sub>2</sub> receptor ligands using live recombinant HEK293T cellsLukas Grätz, Katharina Tropmann, Merlin Bresinsky, et al.
European Journal of Medicinal Chemistry|February 6, 2021
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H<sub>2</sub>R and D<sub>3</sub>RSabrina Biselli, Merlin Bresinsky, Katharina Tropmann, et al.
Journal of Medicinal Chemistry|June 10, 2021
Abolishing Dopamine D<sub>2long</sub>/D<sub>3</sub> Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H<sub>2</sub> Receptor AgonistsKatharina Tropmann, Merlin Bresinsky, Lisa Forster, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2021
Cardiac Effects of Novel Histamine H<sub>2</sub> Receptor AgonistsUlrich Gergs, Maren L Büxel, Merlin Bresinsky, et al.
Archiv Der Pharmazie|June 1, 2022
Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysisMerlin Bresinsky, Jessica M Strasser, Alexander Hubmann, et al.
ACS Chemical Neuroscience|May 6, 2022
Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 TauopathyGurpreet Singh, Peng Liu, Katherine R Yao, et al.
European Journal of Medicinal Chemistry|December 2, 2020
Structural modifications in the distal, regulatory region of histamine H<sub>3</sub> receptor antagonists leading to the identification of a potent anti-obesity agentKatarzyna Szczepańska, Steffen Pockes, Sabina Podlewska, et al.
ACS Pharmacology & Translational Science|January 21, 2022
Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314Merlin Bresinsky, Jessica M Strasser, Bernadette Vallaster, et al.
Pageof 1